Bortezomib is an anti-cancer medication used to treat multiple myeloma and lymphoma. It works by inhibiting proteasome activity, leading to cancer cell death. Bortezomib is effective in managing hematological malignancies. In summary, Bortezomib is beneficial for treating specific blood cancers.
Bortezomib inhibits the proteasome, disrupting protein degradation and inducing apoptosis in cancer cells.


